近日，全国中成药集采中选结果陆续落地，涉及内科、骨伤科、眼科、肿瘤、心血管系统以及妇科用药 6 个治疗领域的多种临床常用中成药，共有 68 个中选代表品。此次集采平均降幅高达 49%，这意味着患者药费负担进一步减轻。
全国中成药集采由 30 个省、区、市组成全国性采购联盟，药品种类涵盖面广，包括治疗效果显著的内服药、外用药等。此次中选的药品品种丰富，平均降幅高达 49%，远高于过去的中成药采购价格。这将显著降低患者的医药负担，改善医疗体系负担。
此次全国中成药集采是国家医药管理局为解决药品采购问题，降低医疗费用采取的重要举措。通过集中采购，优化资源配置，降低中间环节，实现药品采购价格的合理回归。未来，随着中成药集采的进一步完善，患者的用药负担将继续减轻，有望实现看病不贵、用药不贵的目标。
新闻翻译：
Title: National Chinese Herbal Medicine Price Reduction Reaches Average 49%
Keywords: National Chinese Herbal Medicine Price Reduction, Average Discount Rate, Patient Drug Burden
Text:
Recently, the selected results of the national Chinese herbal medicine procurement have been gradually implemented, covering a wide range of clinical commonly used Chinese herbal medicines for treating various diseases, including internal medicine, orthopedic, ophthalmology, oncology, cardiovascular system, and gynecology. A total of 68 products were selected for purchase, with an average discount rate of 49%. This means that the drug burden on patients has been further reduced.
The national Chinese herbal medicine procurement project, involving 30 provinces, autonomous regions, and municipalities, is a national project for procurement of Chinese herbal medicines. The selected products cover a wide range of drug categories, including orally administered and topical medications. The average discount rate of 49% for the selected products is significantly higher than the previous procurement prices of Chinese herbal medicines. This will significantly reduce the patients’ drug burden and alleviate the burden on the medical system.
The national Chinese herbal medicine procurement project is one of the important measures taken by the State 药品管理局 to address the problem of drug procurement and reduce medical expenses. By optimizing resource allocation, reducing intermediate links, and achieving drug procurement prices, the project aims to achieve the goal of affordable healthcare and drug prices that are not too high. In the future, with the continuous improvement of the national Chinese herbal medicine procurement project, patients’ drug burdens will continue to be reduced, and the goal of accessible healthcare and affordable drug prices will be closer to being achieved.
【来源】http://www.chinanews.com/cj/2023/11-01/10104502.shtml
Views: 1